Published in
Elsevier, Lancet Haematology, 9(6), p. e448-e458, 2019
DOI: 10.1016/s2352-3026(19)30109-7
Links
Tools
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
Journal article published in 2019 by
Saad Zafar Usmani,
Fredrik Schjesvold,
Albert Oriol,
Lionel Karlin,
Michele Cavo 
,
Robert M. Rifkin,
Habte Aragaw Yimer,
Richard LeBlanc,
Naoki Takezako,
Robert Donald McCroskey,
Andrew Boon Ming Lim,
Kenshi Suzuki,
Hiroshi Kosugi,
George Grigoriadis,
Irit Avivi
and other authors.
,
Robert M. Rifkin,
Habte Aragaw Yimer,
Richard LeBlanc,
Naoki Takezako,
Robert Donald McCroskey,
Andrew Boon Ming Lim,
Kenshi Suzuki,
Hiroshi Kosugi,
George Grigoriadis,
Irit Avivi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 